Copyright
©2013 Baishideng Publishing Group Co.
World J Clin Cases. Nov 16, 2013; 1(8): 249-255
Published online Nov 16, 2013. doi: 10.12998/wjcc.v1.i8.249
Published online Nov 16, 2013. doi: 10.12998/wjcc.v1.i8.249
Table 1 Overall distribution of bacteria isolated in control and test groups n (%)
Bacteria type | Control (n = 182) | Test (n = 156) | Total | ||
PSB | N-PSB | PSB | N-PSB | ||
Facultative GNB | 2 (1.1) | 17 (9.3) | 5 (3.2) | 21 (13.5) | 45 (13.4) |
Aerobic GPB | 6 (3.2) | 11 (6.04) | - | 20 (12.8) | 37 (10.9) |
Aerobic GNC | - | 9 (4.9) | - | 8 (5.1) | 17 (5.02) |
Facultative GPC | 3 (1.64) | 62 (34.1) | 6 (3.9) | 72 (46.2) | 143 (42.3) |
Anaerobic GNB | 17 (9.3) | 21 (11.5) | 3 (1.9) | - | 40 (11.8) |
Anaerobic GPB | - | 16 (8.8) | - | 15 (9.6) | 31 (9.2) |
Anaerobic GNC | 11 (6.04) | - | 6 (3.9) | - | 17 (5) |
Anaerobic GPC | - | 7 (3.8) | - | - | 7 (2.1) |
Totals | 39 | 143 | 20 | 136 | 338 |
Table 2 Distribution and bacteria isolated at control and test sites at baseline, 5 and 13 wk n (%)
Baseline | 5 wk | 13 wk | ||||
Control | Test | Control | Test | Control | Test | |
Actinomycesnaeslundii FG+veR | 3 (3.9) | - | - | - | 1 (1.7) | 1 (1.6) |
Actinomycesviscosus FG+veR | 2 (2.6) | - | - | - | 1 (1.7) | 1 (1.6) |
Bifidobacterium spp FG+veR | 4 (5.2) | 3 (7.1) | 2 (4) | 2 (3.6) | 1 (1.7) | 3 (4.9) |
Clostridium spp FG+veR | - | - | 7 (14) | 6 (11.3) | - | - |
Diphtheroid bacilli AG+veR | 2 (2.6) | 4 (9.5) | 2 (4) | 2 (3.6) | 3 (5.3) | 1 (1.6) |
Escherichia coli FG-veR | - | - | 1 (2) | 2 (3.6) | - | - |
Eubacterium spp FG+veR1 | 1 (1.3) | - | - | 2 (3.6) | - | - |
Fusobacteriumnucleatum AnG-veR1 | 2 (2.6) | - | 3 (6) | 4 (7.5) | 8 (14.2) | - |
Haemophilus spp FG-veR | 10 (13.1) | 3 (7.1) | 4 (8) | 2 (3.6) | 5 (8.9) | 3 (4.9) |
Coagulase-negative Staphylococci FG+veC | 2 (2.6) | 2 (4.7) | 2 (4) | 1 (1.8) | - | 4 (6.5) |
Neisserria spp AG-veC | 8 (10.5) | 2 (4.7) | 2 (4) | 2 (3.6) | 1 (1.7) | - |
Peptostreptococcus AnG+veC | 5 (6.5) | - | - | - | - | - |
Porphyromonasgingivalis AnG-veR1 | - | - | - | - | 2 (3.2) | - |
Prevotellaintermedia AnG-veR1 | 1 (1.3) | 1 (2.3) | 1 (2) | 1 (1.8) | 8 (14.2) | - |
Propionibacteriumgranulosum FG+veR | - | 1 (2.3) | - | - | - | - |
Staphylococcus aureus FG+veC | 2 (2.6) | 1 (2.3) | 3 (6) | 7 (13.2) | - | 2 (3.2) |
Veillonellaparvula AnG-veC1 | 1 (1.3) | 1 (2.3) | 3 (6) | 1 (1.8) | 10 (17.8) | 1 (1.6) |
Streptococci AG-veC | 25 (32.8) | 15 (35.7) | 15 (30) | 19 (35.8) | 11 (19.6) | 39 (63.9) |
Campylobacter rectus FG-veR | 6 (7.8) | 4 (9.5) | 3 (6) | - | 4 (7.1) | 2 (3.2) |
Treponemadenticola AnG-veC1 | 1 (1.3) | 2 (4.7) | 1 (2) | 1 (1.8) | - | - |
Gemella spp FG+veC | - | - | - | - | 2 (3.2) | |
Filifactoralocis FG+veR | 1 (1.3) | 3 (7.1) | 1 (2) | 1 (1.8) | 1 (1.7) | 2 (3.2) |
Total (n) | 76 | 42 | 50 | 53 | 56 | 61 |
P value | 0.595 | 0.895 | 0.0062 |
Table 3 Statistical data on the distribution of bacteria isolated in control and test groups for gram stain, atmosphere of growth, morphological properties and pathogenicity at baseline, 5 and 13 wk
Type of bacteria | Control | Test | χ2 | P value |
Baseline | ||||
Aerobic/facultative | 55 | 71 | 4.913 | 0.0839 |
Anaerobic | 45 | 29 | ||
Gram-positive | 69 | 71 | 2.391 | 0.00521 |
Gram-negative | 31 | 29 | ||
Cocci | 72 | 58 | 2.598 | 0.00181 |
Rods | 28 | 42 | ||
5 wk | ||||
Aerobic/facultative | 60 | 62 | 0.721 | 0.02511 |
Anaerobic | 40 | 38 | ||
Gram-positive | 75 | 75 | 0.593 | 0.01341 |
Gram-negative | 25 | 25 | ||
Cocci | 65 | 51 | 0.398 | 0.00311 |
Rods | 35 | 45 | ||
13 wk | ||||
Aerobic/facultative | 43 | 85 | 5.821 | 0.00511 |
Anaerobic | 57 | 15 | ||
Gram-positive | 39 | 80 | 6.321 | 0.00321 |
Gram-negative | 61 | 20 | ||
Cocci | 38 | 55 | 7.229 | 0.00051 |
Rods | 72 | 35 |
Table 4 Distribution of bacteria isolated in the control group at baseline, 5 and 13 wk
Time | Bacteria (control group) | Bacteria (test group) | ||||
Anaerobic | Gram-negative | Rod-shaped | Anaerobic | Gram-negative | Rod-shaped | |
Baseline | 45% | 31% | 28% | 29% | 29% | 42% |
5 wk | 40% | 25% | 35% | 38% | 25% | 45% |
13 wk | 57% | 61% | 72% | 15% | 20% | 35% |
2 | 6.022 | 2.091 | 5.412 | 10.171 | 5.021 | 6.118 |
P value | 0.089 | 0.0211 | 0.098 | 0.081 | 0.285 | 0.192 |
- Citation: Saini M, Singh Y, Garg R, Pandey A. Priming the tooth surface with chlorhexidine and antibacterial activity of resin cement. World J Clin Cases 2013; 1(8): 249-255
- URL: https://www.wjgnet.com/2307-8960/full/v1/i8/249.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v1.i8.249